HL7 Terminology (THO)
7.2.0 - Publication
HL7 Terminology (THO)
7.2.0 - Publication
This page is part of the HL7 Terminology (v7.2.0: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
| Active as of 2026-04-14 | Maturity Level: 1 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="research-study-purpose-type"/>
<meta>
<profile
value="http://hl7.org/fhir/StructureDefinition/shareablecodesystem"/>
</meta>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem research-study-purpose-type</b></p><a name="research-study-purpose-type"> </a><a name="hcresearch-study-purpose-type"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/R5/shareablecodesystem.html">Shareable CodeSystem</a></p></div><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/research-study-purpose-type</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">treatment<a name="research-study-purpose-type-treatment"> </a></td><td>Treatment Study</td><td>One or more interventions are being evaluated for treating a disease, syndrome, or condition.</td></tr><tr><td style="white-space:nowrap">prevention<a name="research-study-purpose-type-prevention"> </a></td><td>Prevention Study</td><td>One or more interventions are being evaluated for preventing the development of a disease or condition.</td></tr><tr><td style="white-space:nowrap">diagnostic<a name="research-study-purpose-type-diagnostic"> </a></td><td>Diagnostic Study</td><td>One or more methods are being evaluated for use in detecting a disease or condition, typically in persons who have symptoms or signs of the condition. For example, a mammography to evaluate a palpable mass.</td></tr><tr><td style="white-space:nowrap">screening<a name="research-study-purpose-type-screening"> </a></td><td>Screening Study</td><td>One or more methods are being evaluated for use in detecting a disease or condition, in people who do not yet show symptoms or signs of the condition. For example, a mammography every 2 years in a woman with no current breast concerns.</td></tr><tr><td style="white-space:nowrap">supportive-care<a name="research-study-purpose-type-supportive-care"> </a></td><td>Supportive Care Study</td><td>One or more interventions are being evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function.</td></tr><tr><td style="white-space:nowrap">health-services-research<a name="research-study-purpose-type-health-services-research"> </a></td><td>Health Services Research</td><td>An investigation for evaluating the delivery, processes, management, organization, or financing of health care.</td></tr><tr><td style="white-space:nowrap">basic-science<a name="research-study-purpose-type-basic-science"> </a></td><td>Basic Science</td><td>An investigation to increase general scientific knowledge, such as examining the mechanism of action (for example, physiology or biomechanics) of a disease process or intervention.</td></tr><tr><td style="white-space:nowrap">device-feasibility<a name="research-study-purpose-type-device-feasibility"> </a></td><td>Device Feasibility Study</td><td>An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial.</td></tr><tr><td style="white-space:nowrap">safety<a name="research-study-purpose-type-safety"> </a></td><td>Safety Study</td><td>One or more interventions are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)</td></tr><tr><td style="white-space:nowrap">risk-association<a name="research-study-purpose-type-risk-association"> </a></td><td>Risk Association Study</td><td>One or more conditions or non-interventional exposures are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)</td></tr><tr><td style="white-space:nowrap">efficacy<a name="research-study-purpose-type-efficacy"> </a></td><td>Efficacy Study</td><td>One or more interventions are being evaluated for how well they achieve their intended purpose, such as the ability to treat or prevent a disease, syndrome, or condition.</td></tr><tr><td style="white-space:nowrap">pharmacokinetic<a name="research-study-purpose-type-pharmacokinetic"> </a></td><td>Pharmacokinetic Study</td><td>A study of the process or processes by which a drug is absorbed, distributed, metabolized, or eliminated by the body.</td></tr><tr><td style="white-space:nowrap">pharmacodynamic<a name="research-study-purpose-type-pharmacodynamic"> </a></td><td>Pharmacodynamic Study</td><td>A study of the mechanism of drug action, biochemical effect, or physiological effect of a drug.</td></tr><tr><td style="white-space:nowrap">bioequivalence<a name="research-study-purpose-type-bioequivalence"> </a></td><td>Bioequivalence Study</td><td>A study comparing two drug formulations to evaluate similarity in pharmacokinetic effects to determine if they are therapeutically interchangeable.</td></tr><tr><td style="white-space:nowrap">dose-response<a name="research-study-purpose-type-dose-response"> </a></td><td>Dose-Response Study</td><td>A study evaluating the relationship between the amount of a substance or degree of exposure and the resulting effect or biological response.</td></tr><tr><td style="white-space:nowrap">pharmacogenetic<a name="research-study-purpose-type-pharmacogenetic"> </a></td><td>Pharmacogenetic Study</td><td>A study evaluating how specific gene variations affect individual drug responses.</td></tr><tr><td style="white-space:nowrap">pharmacogenomic<a name="research-study-purpose-type-pharmacogenomic"> </a></td><td>Pharmacogenomic Study</td><td>A study evaluating how multiple gene variations affect individual drug responses.</td></tr><tr><td style="white-space:nowrap">pharmacoeconomic<a name="research-study-purpose-type-pharmacoeconomic"> </a></td><td>Pharmacoeconomic Study</td><td>A study evaluating the economic costs and value of a drug. This may include cost-effectiveness, cost-benefit, and cost-utility analyses.</td></tr><tr><td style="white-space:nowrap">incidence<a name="research-study-purpose-type-incidence"> </a></td><td>Incidence Study</td><td>A study that assesses the occurrence of new cases of disease, condition, or injury in a defined population over a specified period of time.</td></tr><tr><td style="white-space:nowrap">prevalence<a name="research-study-purpose-type-prevalence"> </a></td><td>Prevalence Study</td><td>A study that assesses the proportion of members of a population who have a particular disease, condition, or injury at a specified point in time or over a specified period of time.</td></tr><tr><td style="white-space:nowrap">prediction<a name="research-study-purpose-type-prediction"> </a></td><td>Prediction Study</td><td>One or more methods are being evaluated for use in predicting the risk of a disease or condition.</td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="brr"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="1"/>
</extension>
<url
value="http://terminology.hl7.org/CodeSystem/research-study-purpose-type"/>
<version value="1.0.0"/>
<name value="ResearchStudyPurposeType"/>
<title value="Research Study Purpose Type"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-04-14T16:55:11+11:00"/>
<publisher value="Health Level Seven International"/>
<contact>
<telecom>
<system value="url"/>
<value value="http://hl7.org"/>
</telecom>
<telecom>
<system value="email"/>
<value value="hq@HL7.org"/>
</telecom>
</contact>
<description value="Codes for the intent of the study."/>
<copyright
value="This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license"/>
<caseSensitive value="true"/>
<valueSet
value="http://terminology.hl7.org/ValueSet/research-study-purpose-type"/>
<content value="complete"/>
<concept>
<code value="treatment"/>
<display value="Treatment Study"/>
<definition
value="One or more interventions are being evaluated for treating a disease, syndrome, or condition."/>
</concept>
<concept>
<code value="prevention"/>
<display value="Prevention Study"/>
<definition
value="One or more interventions are being evaluated for preventing the development of a disease or condition."/>
</concept>
<concept>
<code value="diagnostic"/>
<display value="Diagnostic Study"/>
<definition
value="One or more methods are being evaluated for use in detecting a disease or condition, typically in persons who have symptoms or signs of the condition. For example, a mammography to evaluate a palpable mass."/>
</concept>
<concept>
<code value="screening"/>
<display value="Screening Study"/>
<definition
value="One or more methods are being evaluated for use in detecting a disease or condition, in people who do not yet show symptoms or signs of the condition. For example, a mammography every 2 years in a woman with no current breast concerns."/>
</concept>
<concept>
<code value="supportive-care"/>
<display value="Supportive Care Study"/>
<definition
value="One or more interventions are being evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function."/>
</concept>
<concept>
<code value="health-services-research"/>
<display value="Health Services Research"/>
<definition
value="An investigation for evaluating the delivery, processes, management, organization, or financing of health care."/>
</concept>
<concept>
<code value="basic-science"/>
<display value="Basic Science"/>
<definition
value="An investigation to increase general scientific knowledge, such as examining the mechanism of action (for example, physiology or biomechanics) of a disease process or intervention."/>
</concept>
<concept>
<code value="device-feasibility"/>
<display value="Device Feasibility Study"/>
<definition
value="An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial."/>
</concept>
<concept>
<code value="safety"/>
<display value="Safety Study"/>
<definition
value="One or more interventions are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)"/>
</concept>
<concept>
<code value="risk-association"/>
<display value="Risk Association Study"/>
<definition
value="One or more conditions or non-interventional exposures are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)"/>
</concept>
<concept>
<code value="efficacy"/>
<display value="Efficacy Study"/>
<definition
value="One or more interventions are being evaluated for how well they achieve their intended purpose, such as the ability to treat or prevent a disease, syndrome, or condition."/>
</concept>
<concept>
<code value="pharmacokinetic"/>
<display value="Pharmacokinetic Study"/>
<definition
value="A study of the process or processes by which a drug is absorbed, distributed, metabolized, or eliminated by the body."/>
</concept>
<concept>
<code value="pharmacodynamic"/>
<display value="Pharmacodynamic Study"/>
<definition
value="A study of the mechanism of drug action, biochemical effect, or physiological effect of a drug."/>
</concept>
<concept>
<code value="bioequivalence"/>
<display value="Bioequivalence Study"/>
<definition
value="A study comparing two drug formulations to evaluate similarity in pharmacokinetic effects to determine if they are therapeutically interchangeable."/>
</concept>
<concept>
<code value="dose-response"/>
<display value="Dose-Response Study"/>
<definition
value="A study evaluating the relationship between the amount of a substance or degree of exposure and the resulting effect or biological response."/>
</concept>
<concept>
<code value="pharmacogenetic"/>
<display value="Pharmacogenetic Study"/>
<definition
value="A study evaluating how specific gene variations affect individual drug responses."/>
</concept>
<concept>
<code value="pharmacogenomic"/>
<display value="Pharmacogenomic Study"/>
<definition
value="A study evaluating how multiple gene variations affect individual drug responses."/>
</concept>
<concept>
<code value="pharmacoeconomic"/>
<display value="Pharmacoeconomic Study"/>
<definition
value="A study evaluating the economic costs and value of a drug. This may include cost-effectiveness, cost-benefit, and cost-utility analyses."/>
</concept>
<concept>
<code value="incidence"/>
<display value="Incidence Study"/>
<definition
value="A study that assesses the occurrence of new cases of disease, condition, or injury in a defined population over a specified period of time."/>
</concept>
<concept>
<code value="prevalence"/>
<display value="Prevalence Study"/>
<definition
value="A study that assesses the proportion of members of a population who have a particular disease, condition, or injury at a specified point in time or over a specified period of time."/>
</concept>
<concept>
<code value="prediction"/>
<display value="Prediction Study"/>
<definition
value="One or more methods are being evaluated for use in predicting the risk of a disease or condition."/>
</concept>
</CodeSystem>
IG © 2020+ HL7 International - Vocabulary Work Group.
Package hl7.terminology#7.2.0 based on FHIR 5.0.0.
Generated
2026-06-14
Links: Table of Contents |
QA Report
| Version History 
|
|
Propose a change